IN-DATE
IS3: Glaukos iStent Infinite W Trabecular Micro-Bypass System (No Box)
Sign in to add this product to your favorites!
| Price: | $1,889.00 EACH |
|---|---|
| In Stock: | 0 eaches |
| Expiration: | In-Date |
We currently do not have this item in stock, but we can email you as soon as it is available.
Related Items
QUICK VIEW
| GTS100R $1,899.00 per box of 1 Glaukos iStent Trabecular Micro-Bypass Stent System, Right Exp: 06-2026 Units in stock: 1 box of 1 | Order Qty |
QUICK VIEW
| S1.1545 $49.00 EACH FCI LacriJet 45mm Exp: 09-2025 Units in stock: 1 | Order Qty |
QUICK VIEW
| CP250 $699.00 per box of 1 New World Medical Ahmed ClearPath Glaucoma Drainage Device Exp: 02-2026 Units in stock: 2 box of 1 | Order Qty |
Manufacturer
Glaukos is a medical technology company specializing in innovative treatments for glaucoma, corneal disorders, and retinal diseases. The company is best known for pioneering minimally invasive glaucoma surgery (MIGS) with the iStent family of devices, which are implanted during cataract surgery to reduce intraocular pressure in patients with open-angle glaucoma. Glaukos has expanded its portfolio to include the iStent inject W and iStent infinite, as well as the iDose TR, a sustained-release intraocular drug delivery implant. The company is also advancing therapies in corneal cross-linking and retinal disease through its pipeline of biologics and sustained drug delivery platforms. Glaukos is focused on transforming the standard of care in chronic eye disease with safe, effective, and minimally invasive solutions.
